The impact of neonatal 17-hydroxyprogesterone cutoff determination in a public newborn screening program for congenital adrenal hyperplasia in Southern Brazil: 3 years’ experience
Congenital adrenal hyperplasia (CAH) occurs due to enzyme defects in adrenal steroidogenesis. The 21-hydroxylase deficiency accounts for 90–95% of cases, triggering accumulation of 17-hydroxyprogesterone (17-OHP). Early diagnosis through neonatal screening allows adequate treatment and reduced morta...
Main Authors: | Simone Martins de Castro, Paloma Wiest, Poli Mara Spritzer, Cristiane Kopacek |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-10-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/aop/ec-23-0162/ec-23-0162.xml |
Similar Items
-
Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia
by: Wen-Hsuan Tsai, et al.
Published: (2020-09-01) -
Determination of Variation in Neonatal Serum 17 Hydroxyprogesterone Levels in Relation with Gestational Age & Low Birth Weight
by: Ammar ul Hassan, Zujaja Hina Haroon, Muhammad Anwar, Muhammad Younas, Muhammad Usman Munir, Sobia Irum Kirmani
Published: (2023-09-01) -
Adrenal Hyperandrogenism: Multidisciplinary Approach to Solving Problemss
by: L.A. Lutsenko
Published: (2016-11-01) -
Children with premature pubarche: is an alterated neonatal 17-Ohp screening test a predictive factor?
by: Paolo Cavarzere, et al.
Published: (2018-01-01) -
Newborn screening for congenital adrenal hyperplasia in New York State
by: Melissa Pearce, et al.
Published: (2016-06-01)